GlykoGen
GlykoGen is a biotech company that specializes in the development of anti-glycan antibodies.
GlykoGen is a company in biopharma, biotechnology, pharmaceutical based in Europe, Middle East, and Africa (EMEA), founded in 2016.
The company sits in the biopharma, biotechnology, pharmaceutical segment, where it competes on its core product or service.
The business is associated with Europe, Middle East, and Africa (EMEA).
It is recorded at the Private company stage.
| Sector | Biopharma, Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2016 |
| Stage | Private company |
Website: glykogen.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account